Toll-like Receptor Ligands Energize Peptide Vaccines through Multiple Paths
Open Access
- 1 September 2007
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (17), 7945-7947
- https://doi.org/10.1158/0008-5472.can-07-1652
Abstract
The potential of vaccines for cancer therapy or prevention has yet to be realized. Recently, we showed that using an immunologic adjuvant composed of a Toll-like receptor (TLR) ligand can increase the production of antitumor CTLs produced by a peptide vaccine in a mouse model of breast cancer. By increasing the cross talk between the innate and adaptive immune systems, TLR ligands can drive expansion and memory of CTLs that can destroy cancer cells. [Cancer Res 2007;67(17):7945–7]Keywords
This publication has 20 references indexed in Scilit:
- Effector and Memory CTL DifferentiationAnnual Review of Immunology, 2007
- Peptide Vaccine Given with a Toll-Like Receptor Agonist Is Effective for the Treatment and Prevention of Spontaneous Breast TumorsCancer Research, 2007
- The Terminology Issue for Myeloid-Derived Suppressor CellsCancer Research, 2007
- Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinomaThe Journal of Experimental Medicine, 2005
- Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune ActivityClinical Cancer Research, 2005
- Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell FunctionScience, 2005
- Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivityBlood, 2003
- CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytesNature, 2003
- Creating space: an antigen-independent, CpG-induced peripheral expansion of naive and memory T lymphocytes in a full T-cell compartmentBlood, 2002
- In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccineNature, 1989